Literature DB >> 7536616

Mapping of B-cell determinants in the nucleocapsid protein of Puumala virus: definition of epitopes specific for acute immunoglobulin G recognition in humans.

A Lundkvist1, S Björsten, B Niklasson, N Ahlborg.   

Abstract

The complete amino acid sequence of the Puumala (PUU) virus nucleocapsid protein (N), deduced from the genome of the prototype strain Sotkamo, was synthesized as decapeptides with 5-amino-acid overlaps. By use of the PEPSCAN method, 86 peptides were examined for reactivity with sera from serologically confirmed nephropathia epidemica (NE) patients and 11 PUU virus N-specific bank vole monoclonal antibodies. The human sera showed reactivity with several different regions, while only one of the monoclonal antibodies reacted with one single peptide. Sequences were selected by this PEPSCAN analysis of human antibody reactivities, and five 15-amino-acid peptides were synthesized and evaluated as antigens by an enzyme-linked immunosorbent assay (ELISA). Peptide-reactive antibodies of the immunoglobulin M (IgM) class were measured in serum samples drawn from patients with acute NE. In comparison with the results of a mu-capture IgM ELISA using native PUU virus antigen, only a few serum samples were found positive (sensitivity, 2 to 10%). Interestingly, when antibodies of the IgG class were measured, the sensitivities of the five peptide ELISAs were found to be 79, 46, 2, 100, and 40%, respectively, as compared with the sensitivity of an IgG ELISA based on native viral antigen. The IgG reactivities of sequentially drawn sera from NE patients with the two peptides giving the highest assay sensitivities were analyzed and compared with their reactivities with native viral antigen. All patients had detectable anti-peptide IgG in the acute-phase sample, which, however, had totally declined in samples drawn after 2 years. The opposite pattern was seen with native viral antigen, in which case all patients showed the highest levels of specific IgG after 2 years. The results suggest the presence of epitopes specific for the acute IgG response.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7536616      PMCID: PMC170105          DOI: 10.1128/cdli.2.1.82-86.1995

Source DB:  PubMed          Journal:  Clin Diagn Lab Immunol        ISSN: 1071-412X


  28 in total

1.  Detection of nephropathia epidemica (Puumala virus)-specific immunoglobulin M by enzyme-linked immunosorbent assay.

Authors:  B Niklasson; T Kjelsson
Journal:  J Clin Microbiol       Date:  1988-08       Impact factor: 5.948

2.  Antigenic relationship between hantaviruses analysed by immunoprecipitation.

Authors:  H Sheshberadaran; B Niklasson; E A Tkachenko
Journal:  J Gen Virol       Date:  1988-10       Impact factor: 3.891

Review 3.  Molecular biology of the Bunyaviridae.

Authors:  R M Elliott
Journal:  J Gen Virol       Date:  1990-03       Impact factor: 3.891

4.  Detection of antibodies to human T-lymphotropic virus type III by using a synthetic peptide of 21 amino acid residues corresponding to a highly antigenic segment of gp41 envelope protein.

Authors:  J J Wang; S Steel; R Wisniewolski; C Y Wang
Journal:  Proc Natl Acad Sci U S A       Date:  1986-08       Impact factor: 11.205

5.  Strategies for epitope analysis using peptide synthesis.

Authors:  H M Geysen; S J Rodda; T J Mason; G Tribbick; P G Schoofs
Journal:  J Immunol Methods       Date:  1987-09-24       Impact factor: 2.303

6.  Evaluation of enzyme-linked immunosorbent assays with two synthetic peptides of Epstein-Barr virus for diagnosis of infectious mononucleosis.

Authors:  A Linde; B Kallin; J Dillner; J Andersson; L Jägdahl; A Lindvall; B Wahren
Journal:  J Infect Dis       Date:  1990-05       Impact factor: 5.226

7.  Immunoblot analysis of the serological response in Hantavirus infections.

Authors:  L Zöller; J Scholz; R Stohwasser; L B Giebel; K K Sethi; E K Bautz; G Darai
Journal:  J Med Virol       Date:  1989-03       Impact factor: 2.327

8.  Serotypic classification of hantaviruses by indirect immunofluorescent antibody and plaque reduction neutralization tests.

Authors:  P W Lee; C J Gibbs; D C Gajdusek; R Yanagihara
Journal:  J Clin Microbiol       Date:  1985-12       Impact factor: 5.948

9.  Rabbit and human antibodies to a repeated amino acid sequence of a Plasmodium falciparum antigen, Pf 155, react with the native protein and inhibit merozoite invasion.

Authors:  K Berzins; H Perlmann; B Wåhlin; J Carlsson; M Wahlgren; R Udomsangpetch; A Björkman; M E Patarroyo; P Perlmann
Journal:  Proc Natl Acad Sci U S A       Date:  1986-02       Impact factor: 11.205

10.  Nephropathia epidemica: incidence of clinical cases and antibody prevalence in an endemic area of Sweden.

Authors:  B Niklasson; J Leduc; K Nyström; L Nyman
Journal:  Epidemiol Infect       Date:  1987-10       Impact factor: 2.451

View more
  16 in total

1.  Diagnostic potential of puumala virus nucleocapsid protein expressed in Drosophila melanogaster cells.

Authors:  K Brus Sjölander; I Golovljova; A Plyusnin; A Lundkvist
Journal:  J Clin Microbiol       Date:  2000-06       Impact factor: 5.948

2.  Epitope mapping of B-cell determinants on the 15-kilodalton lipoprotein of Treponema pallidum (Tpp15) with synthetic peptides.

Authors:  R E Baughn; M Demecs; L H Taber; D M Musher
Journal:  Infect Immun       Date:  1996-07       Impact factor: 3.441

3.  Rapid and specific detection of Sin Nombre virus antibodies in patients with hantavirus pulmonary syndrome by a strip immunoblot assay suitable for field diagnosis.

Authors:  B Hjelle; S Jenison; N Torrez-Martinez; B Herring; S Quan; A Polito; S Pichuantes; T Yamada; C Morris; F Elgh; H W Lee; H Artsob; R Dinello
Journal:  J Clin Microbiol       Date:  1997-03       Impact factor: 5.948

4.  Competitive Homogeneous Immunoassay for Rapid Serodiagnosis of Hantavirus Disease.

Authors:  Satu Hepojoki; Juuso Rusanen; Jussi Hepojoki; Visa Nurmi; Antti Vaheri; Åke Lundkvist; Klaus Hedman; Olli Vapalahti
Journal:  J Clin Microbiol       Date:  2015-05-13       Impact factor: 5.948

5.  Molecular evolution of Puumala hantavirus.

Authors:  T Sironen; A Vaheri; A Plyusnin
Journal:  J Virol       Date:  2001-12       Impact factor: 5.103

6.  Wild-type Puumala hantavirus infection induces cytokines, C-reactive protein, creatinine, and nitric oxide in cynomolgus macaques.

Authors:  J Klingström; A Plyusnin; A Vaheri; A Lundkvist
Journal:  J Virol       Date:  2002-01       Impact factor: 5.103

7.  Isolation and characterization of a hantavirus from Lemmus sibiricus: evidence for host switch during hantavirus evolution.

Authors:  O Vapalahti; A Lundkvist; V Fedorov; C J Conroy; S Hirvonen; A Plyusnina; K Nemirov; K Fredga; J A Cook; J Niemimaa; A Kaikusalo; H Henttonen; A Vaheri; A Plyusnin
Journal:  J Virol       Date:  1999-07       Impact factor: 5.103

8.  Antigenic properties and diagnostic potential of puumala virus nucleocapsid protein expressed in insect cells.

Authors:  O Vapalahti; A Lundkvist; H Kallio-Kokko; K Paukku; I Julkunen; H Lankinen; A Vaheri
Journal:  J Clin Microbiol       Date:  1996-01       Impact factor: 5.948

9.  Recombination in Tula hantavirus evolution: analysis of genetic lineages from Slovakia.

Authors:  C Sibold; H Meisel; D H Krüger; M Labuda; J Lysy; O Kozuch; M Pejcoch; A Vaheri; A Plyusnin
Journal:  J Virol       Date:  1999-01       Impact factor: 5.103

10.  Cross-protection against challenge with Puumala virus after immunization with nucleocapsid proteins from different hantaviruses.

Authors:  Cristina de Carvalho Nicacio; Marcelo Gonzalez Della Valle; Paula Padula; Ewa Björling; Alexander Plyusnin; Ake Lundkvist
Journal:  J Virol       Date:  2002-07       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.